What questions should I ask about a Prostate Cancer clinical trial

Key Questions to Ask About a Prostate Cancer Clinical Trial

Based on the educational resources available, here are the most important questions you should ask your oncology team when considering a clinical trial:

ABOUT THE TRIAL ITSELF

1. How does this trial relate to my specific situation?

• What stage is my cancer (localized, hormone-sensitive, castration-resistant)?
• How many prior treatments have I had, and does this trial fit where I am in my treatment journey?
• According to the CancerPatientLab webinars on clinical trials, the number of previous treatment lines matters significantly for trial eligibility.

2. What is the scientific rationale for this trial?

• What biomarker or genetic mutation does this trial target?
• For example, if you have a BRCA mutation, PARP inhibitors may be relevant. If you have an ALK fusion, targeted therapies exist specifically for that.
• Ask: "Why do you think this trial is a good match for MY cancer's genetics?"

3. What phase is the trial, and what does that mean?

• Phase 1: Testing safety and dosage (smaller group)
• Phase 2: Testing effectiveness (medium group)
• Phase 3: Comparing to standard treatment (larger group)
• Earlier phases have more unknown risks but may offer novel approaches.

ABOUT YOUR SPECIFIC ELIGIBILITY

4. Do I actually meet the inclusion criteria?

• What are the specific requirements (age, prior treatments, organ function, performance status)?
• What would disqualify me (exclusion criteria)?
• Ask for a written copy of these criteria so you understand exactly what's required.

5. What comorbidities (other health conditions) might affect my participation?

• Do you have cardiovascular disease, kidney disease, or active infections that might prevent enrollment?
• According to clinical trial matching resources, these conditions are carefully reviewed.

ABOUT THE TREATMENT APPROACH

6. What drug(s) or combination of drugs will I receive?

• Is this a single drug or a combination therapy?
• How does it work differently from treatments you've already tried?
• What is the FDA approval status? (Approved for prostate cancer? Approved for other cancers? Still experimental?)

7. How is the drug administered, and what's the schedule?

• Intravenous infusion? Oral pills? Injections?
• How often? Weekly? Monthly?
• How long is the trial commitment?

8. What monitoring will happen?

• How often will you have scans (CT, MRI, PSMA-PET)?
• How often will you have blood tests?
• What biomarkers will be tracked? (PSA, circulating tumor DNA, imaging response)
• The webinars emphasize that response monitoring is critical—you need to know if the treatment is working.

ABOUT SIDE EFFECTS & SAFETY

9. What are the known and potential side effects?

• What happened in earlier phases of this trial?
• Which side effects are most common?
• Which are most serious?
• How are side effects managed?

10. What happens if I experience serious side effects?

• Can you stop the trial?
• Will you receive other treatments to manage side effects?
• Who do you contact in an emergency?

ABOUT LOGISTICS & ACCESS

11. Where is the trial located, and what's involved in participating?

• How far is the trial site from your home?
• How often do you need to travel there?
• Are there financial assistance programs for travel/accommodation?
• According to Massive Bio's clinical trial matching resources, travel logistics are a real barrier—this matters.

12. Will the trial cover costs?

• Does the trial sponsor pay for the experimental drug?
• What about standard care costs (scans, blood work, office visits)?
• Will your insurance be billed?

ABOUT YOUR CARE TEAM

13. Who will be managing my care during the trial?

• Is there a principal investigator (PI) you'll work with?
• Can you communicate with your regular oncologist while in the trial?
• What happens to your care after the trial ends?

14. How will decisions be made about continuing or stopping treatment?

• What constitutes "response" to the treatment?
• What would cause the trial to stop your participation?
• Do you have input in these decisions?

ABOUT ALTERNATIVES

15. Why this trial versus other options?

• What are the standard-of-care treatments for my situation?
• How does this trial compare?
• Are there other clinical trials I should consider?
• The webinars emphasize that you should understand your complete treatment landscape.

16. What if I don't qualify or change my mind?

• What are my other treatment options?
• Will declining the trial affect my regular cancer care?

IMPORTANT CONTEXT FROM PROSTATE CANCER EXPERTS

According to the CancerPatientLab webinars on prostate cancer clinical trials:

• Genetic testing is crucial: Most men in community practices don't get comprehensive genomic testing. Ask if you've had NGS (next-generation sequencing) testing. This identifies which trials might work for YOUR specific mutations.

• Treatment sequencing matters: Doctors think carefully about the order of treatments. Ask: "Where does this fit in my overall treatment plan? What comes next if this doesn't work?"

• Combination approaches are increasingly standard: Many newer trials combine multiple drugs (e.g., androgen receptor inhibitors + PARP inhibitors, or immunotherapy + targeted therapy). Understand what you're getting and why.

• Response monitoring is tricky: PSA alone isn't always reliable, especially in castration-resistant prostate cancer. Ask how they'll actually measure if the treatment is working (scans, blood tests, imaging).

QUESTIONS TO ASK YOUR ONCOLOGIST SPECIFICALLY

1. "Based on my genetic testing results, which trials are the best scientific match for my cancer?"
2. "How many patients have been treated with this approach, and what were the results?"
3. "What would make you recommend this trial over standard treatment for me?"
4. "If this trial doesn't work, what's the next step?"
5. "Can I see the trial protocol (the detailed study plan) before deciding?"

---

BEFORE YOU DECIDE

Get a second opinion: The webinars emphasize that having an expert genitourinary (GU) medical oncologist review your case is valuable. If you're not at a major cancer center, consider a telemedicine consultation with a prostate cancer specialist.

Bring someone with you: Clinical trial discussions involve a lot of information. Having a family member or advocate take notes helps.

Take time to decide: You don't need to decide immediately. Ask for written materials and time to review them.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.